The document outlines the agenda for the Targos Biomarker Meeting 2013 being held from February 25-26 at Waldgut Schloss H旦hnscheid in Bad Arolsen, Germany. The meeting will include presentations on predictive biomarkers in various cancers such as lymphomas, melanoma, breast cancer, NSCLC, and sarcomas from researchers and industry representatives. Speakers will discuss topics like the FDA perspective on predictive biomarkers and using biomarkers for targeted cancer therapies. The agenda also includes facility tours of Targos and Pathologie Nordhessen along with discussions and a group photo.